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Abstract
Non-typeable Haemophilus influenzae (NTHi), a common commensal of the human pharynx, is also an opportunistic
pathogen if it becomes established in the lower respiratory tract (LRT). In comparison to colonizing isolates from the upper
airway, LRT isolates, especially those associated with exacerbations of chronic obstructive pulmonary disease, have
increased resistance to the complement- and antibody-dependent, bactericidal effect of serum. To define the molecular
basis of this resistance, mutants constructed in a serum resistant strain using the mariner transposon were screened for loss
of survival in normal human serum. The loci required for serum resistance contribute to the structure of the exposed surface
of the bacterial outer membrane. These included loci involved in biosynthesis of the oligosaccharide component of
lipooligosaccharide (LOS), and vacJ, which functions with an ABC transporter encoded by yrb genes in retrograde trafficking
of phospholipids from the outer to inner leaflet of the cell envelope. Mutations in vacJ and yrb genes reduced the stability of
the outer membrane and were associated with increased cell surface hyrophobicity and phospholipid content. Loss of
serum resistance in vacJ and yrb mutants correlated with increased binding of natural immunoglobulin M in serum as well
as anti-oligosaccharide mAbs. Expression of vacJ and the yrb genes was positively correlated with serum resistance among
clinical isolates. Our findings suggest that NTHi adapts to inflammation encountered during infection of the LRT by
modulation of its outer leaflet through increased expression of vacJ and yrb genes to minimize recognition by bactericidal
anti-oligosaccharide antibodies.
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Introduction
The mucosal surface of the human nasopharynx is serially
colonized by different strains of Haemophilus influenzae [1]. When
host factors allow this opportunistic pathogen to gain access to the
normally sterile parts of the respiratory tract, inflammatory
diseases such as otitis media, sinusitis or pneumonia may result
[2]. Widespread immunization against encapsulated strains with
the type b polysaccharide has greatly reduced the incidence of
invasive disease by H. influenzae in children. However, non-
typeable strains (NTHi), which do not express a capsule, remain
amongst the most common etiologic agents of localized infectious
diseases of the airway in all age groups [3]. The damaged airways
in adults with chronic obstructive pulmonary disease (COPD) are
especially susceptible, and identification of a newly acquired NTHi
isolate in sputum is temporally associated with exacerbations of
disease symptoms and decline in pulmonary function [4,5]. COPD
ranks as the fourth leading cause of death in the US and is rapidly
becoming recognized as a public health problem of similar
proportions in other parts of the world [6,7].
Characteristics of the organism that allow it to transition from
its commensal state in the upper airway and survive the
inflammatory milieu of the lower respiratory tract (LRT) and
elsewhere are poorly understood. In particular, during early
infection this predominantly extracellular pathogen will be
exposed to increasing levels of natural (i.e. pre-existing) antibody
and complement produced locally or extravasated from serum.
For encapsulated H. influenzae, the thick polysaccharide coat
protects the organism from recognition by immunoglobulin, the
activation of complement and complement-dependent bactericidal
activity. For gram-negative bacteria, the exposed surface is its
outer membrane, an asymmetric lipid bilayer consisting of an
outer leaflet of lipid A attached to a polysaccharide (LPS) and an
inner leaflet of phospholipid [8,9,10]. For H. influenzae, LPS is
referred to as a lipooligosaccharide (LOS) because of its more
limited number of attached sugars. There is marked strain to strain
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oligosaccharide epitopes these residues generate indicating that
antigenic variation may contribute to immune evasion by NTHi
[11,12]. Structural features of the surface oligosaccharide that
inhibit complement-dependent killing have been analyzed exten-
sively [13,14,15,16]. The expression of many of these oligosac-
charide components is controlled by highly repetitive DNA
sequences and, as a consequence of slipped stranded mispairing,
the expression of oligosaccharide structures is turned on and off at
high frequency [13,17]. While this would predict that the presence
of bactericidal antibody and complement would select for variants
with increased resistance, many of these structures decorating the
surface oligosaccharide are present on both serum sensitive and
resistant isolates. Therefore, our current understanding does not
fully account for why only some NTHi are serum resistant and
how this phenotype correlates with the pathogenicity of the
species.
In this study, we addressed whether increased resistance to the
complement-mediated bactericidal activity of normal human
serum is a characteristic of isolates from the LRT. We then used
a whole genomic approach to identify the genes required for the
expression of serum resistance among these isolates. We describe
an important role for genes involved in trafficking of phospholipids
in evading natural antibody and the expression of serum resistance
by NTHi.
Results
Lung isolates have increased serum resistance and
decreased binding of natural IgM
Collections of recent clinical isolates maintained with minimal in
vitro passage were compared for their ability to survive following a
60 min incubation in 5% normal human serum (NHS). Bacteri-
cidal activity was complement-dependent, since killing was not
observed in controls using heat-inactivated serum. Sputum isolates
from the lower respiratory tract (LRT) (n=22) were significantly
more serum resistant than colonizing strains (n=25) cultured from
the upper respiratory tract (Fig. 1A). Among the LRT isolates,
those obtained at the time of a COPD exacerbation were the most
serum resistant. Next, we examined whether differences in serum
resistance correlated with the binding of immunoglobulin present
in normal human serum as measured by flow cytometry. There
was no difference between serum resistant and serum sensitive
isolates in binding of IgG (Fig. 1B1). In contrast, the serum
sensitive strains bound significantly more IgM than serum resistant
strains (Fig. 1B2). There was no difference between serum resistant
and serum sensitive strains in killing by baby rabbit serum (2.5%),
which lacks natural antibody to H. influenzae, as a source of
complement (Fig. 1C). Addition of IgM, but not IgG, purified
from NHS to baby rabbit serum significantly enhanced killing of
serum sensitive, but not serum resistant isolates (Fig. 1C). Together
these results demonstrate 1) an association between serum
resistance and the ability of NTHi to infect the LRT and 2) that
resistant isolates bind less natural, bactericidal IgM.
Genetic basis of increased serum resistance
In order to identify the complete set of genes required for serum
resistance in NTHi, we screened mariner transposon mutants
generated in strain R2866, a previously described serum resistant
isolate for which the whole genome sequence was available, for
increased susceptibility to NHS [18]. A total of 6912 mutants were
individually screened to provide ,4-fold representation of open
reading frames. Genomic DNA from candidates showing ,10%
survival was back transformed into the parent, R2866, and these
back transformants were tested to confirm that the insertion
mutation conferred a serum sensitive phenotype. Sixty serum
sensitive mutants (representing 0.87% of the total strains screened)
were identified and for these the mariner insertion site was defined.
We focused on the genes (13 total and 12 of ‘known’ function) for
which there was more than a single ‘hit’(Table 1). Eight loci,
including lgtC, galE, waaQ, lic2A, lex2B, lpsA, yhxB and galU,
function in the biosynthesis of the surface oligosaccharide and
these were not considered further [19]. The most striking effect on
serum resistance (Fig. 2A) was observed with mutations in HI0718
(encoding VacJ, a putative lipoprotein), and in a separate operon
with ‘hits’ in HI1083, HI1085, and HI1086 (encoding orthologs of
other gram-negative species; YrbB, a putative NTP binding
protein; YrbD, an ABC transporter periplasmic protein; and
YrbE, an ABC transporter permease, respectively). VacJ, YrbD
and YrbE each share homology (.60% sequence identity) with
members of the E. coli Mla transport system, which have been
proposed to function in preventing phospholipid accumulation in
the outer leaflet and thereby maintain the lipid asymmetry and the
barrier function of the gram-negative outer membrane [20]. A
double mutant in vacJ and the ABC transporter gene yrbE had a
similar serum sensitive phenotype to that of each mutant, which
confirmed that these may act in the same pathway. The effect on
vacJ is unlikely to be caused by a polar effect of the insertion
mutation, since a mutant in the immediate downstream gene,
HI0719, maintained serum resistance (data not shown). There was
no effect of vacJ or yrb genes on LOS or outer membrane protein
profiles as assessed following separation using tricine gel
electrophoresis followed by silver staining (data not shown).
vacJ and yrb ABC transporter genes contribute to serum
resistance and IgM binding
After incubation in baby rabbit serum, no significant difference
was observed in the binding of rabbit complement factor 3
between wild type and vacJ mutant (data not shown) indicating a
requirement for antibody in the differential susceptibility of the
mutants. To determine whether vacJ and yrbE, B and D mediate
serum resistance by affecting antibody binding, we compared the
deposition of IgG and IgM purified from NHS by flow cytometry.
No detectible effect of these mutations on the binding of IgG was
observed (data not shown). In contrast, there was a significant
increase in the binding of IgM to the mutants (Fig. 2B and 2C). To
Author Summary
Haemophilus influenzae generally colonizes the human
upper respiratory tract. When isolated from the lower
respiratory tract, this opportunistic pathogen is associated
with inflammatory conditions such as pneumonia and
exacerbations of chronic obstructive pulmonary disease
(COPD). Here we show that one of the adaptations made
by H. influenzae isolated from the lower respiratory tract is
increased resistance to the bactericidal effect of antibody
and complement. To define the mechanism for increased
resistance, mutants were screened to identify the com-
plete set of genes required to inhibit killing by antibody
and complement. These included multiple genes that all
contribute to biosynthesis of the organism’s surface
oligosaccharide (lipooligosaccharide), which is targeted
by bactericidal antibody. Our results also revealed a novel
function for additional genes that maintain the lipid
asymmetry of the surface membrane and thereby limit
recognition of the pathogen by anti-oligosaccharide
antibodies.
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PLoS Pathogens | www.plospathogens.org 2 January 2011 | Volume 7 | Issue 1 | e1001247Figure 1. Characterization of clinical isolates. (A) Comparison of serum sensitivity between lower and upper respiratory tract isolates. Survival
was determined over 60 min in 5% normal human serum and expressed relative to controls in which complement was inactivated. Groups included
lower respiratory tract isolates from patients with chronic obstructive pulmonary disease (COPD) at the time of clinical exacerbation (black bars;
n=11); isolates from patients with COPD during clinically stable periods (grey bars; n=11); and upper respiratory tract colonizing strains (white bars;
n=25). Values are the mean of three determinations in triplicate 6 SEM. (B) Comparison of antibody binding in serum resistant (.50% survival in
pooled NHS, black bars; n=10) and serum sensitive (,50% survival in pooled NHS, white bars; n=10) isolates. B1 and B2 show percent of IgG and
IgM bound following incubation in 5% heat-inactivated NHS as determined by flow cytometry, respectively. (C) Serum IgM contributes to bactericidal
killing of clinical isolates of NTHi. Strains were incubated with or without IgG (C1, 0.25 mg/ml) or IgM (C2, 0.07mg/ml) purified from NHS for 60 min in
2.5% baby rabbit serum as a complement source. Percent survival was calculated by viable counts with and without antibody. The mean values of
two independent experiments in triplicate are shown 6 SD,
*P,0.05,
**P,0.01,
***P,0.001. Serum sensitive (SS), Serum resistant (SR).
doi:10.1371/journal.ppat.1001247.g001
Table 1. List of sites with multiple transposon insertions affecting serum resistance in strain R2866.
HI no.
* Gene name Protein_id
# Function
0258 lgtC NP_438427
* UDP-galactose-LOS-galactosyltransferase
0351 galE ZP_00156190.2 UDP-glucose 4-epimerase
0461 ZP_00156296.2 Hypothetical protein
0523 waaQ ZP_00349685.1 ADP-heptose-lipooligosaccharide heptosyltransferase III
0550 lic2A ZP_00156370.1 UDP-galactose-LOS-galactosyltransferase
0653 lex2B ZP_00156456.1 UDP-glucose-LOS-glucosyltransferase
0718 vacJ ZP_00156519.2 Lipoprotein (associated to retrograde PLs trafficking)
0740 yhxB ZP_00156601.1 phosphomannomutase
0765 lpsA ZP_00203076.1 LOS-glycosyltransferase
0812 galU ZP_00156667.2 UTP-glucose-1-phosphate uridylyltransferase
1083 yrbB ZP_00156925.2 Putative NTP binding protein
1085 yrbD ZP_00156927.2 ABC transporter periplasmic protein
1086 yrbE ZP_00203123.1 ABC transporter permease
*NCBI Reference Sequence: NC_000907.1 (Haemophilus influenzae Rd KW20, complete genome).
#NCBI Reference Sequence: NZ_AADP01000001 and NZ_AADP01000002 (Haemophilus influenzae R2866 whole genome).
doi:10.1371/journal.ppat.1001247.t001
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loss of serum resistance of the mutants, IgM purified from human
serum was used with 2.5% baby rabbit serum as a complement
source. Under these conditions each of the mutants was more
susceptible to IgM dependent killing (data not shown). To define
the complement pathway affected, the survival of the mutants was
studied in the presence of Mg-EGTA buffer, which inhibits the
classical pathway. When the classical pathway was inhibited, a
significant increase in the survival of each mutant was observed
(Fig. 2D). The requirement for the classical pathway of com-
plement showed that the anti-bacterial effect of IgM was not
caused by agglutination. Together these results demonstrated that
vacJ and yrbE, B and D are needed for serum resistance in R2866
by limiting the binding of natural IgM that promotes killing via the
classical pathway of complement activation.
vacJ and yrb ABC transporter genes affect binding of
anti-LOS antibody
Next, we considered the target of bactericidal, natural IgM
affected by mutations in vacJ and yrb ABC transporter genes. We
performed FACS analysis to compare the binding of murine mAbs
4C4 and TEPC-15, which bind specifically to LOS components,
Gala1-4Gal and phosphorylcholine, respectively. Since these are
both phase variable LOS epitopes, we first enriched for mAb 4C4
or TEPC-15 positive cells by colony immunoblotting. Mutations in
vacJ and the yrb ABC transporter genes significantly increased
the binding of mAbs 4C4 and TEPC-15 (Fig. 3A and 3B).
Furthermore, mAb 4C4 was bactericidal in the presence of normal
mouse serum as a source of complement and each mutant was
significantly more sensitive compared to the parent strain.
(Fig. 3C). We then investigated whether vacJ affects the antibody
binding to cell surface proteins by flow cytometry in two different
ways. First, we compared binding of the mAb 7B11 to an exposed
epitope on outer membrane protein P2 on strain H782 [21].
However, the mutation in vacJ in strain H782 did not alter the
binding of mAb 7B11 (data not shown). Second, we labeled
exposed lysine residues on cell surface proteins by treating whole
bacteria with the fluorescent dye Cy5. There was no difference in
the levels of bound Cy5 between wild type and vacJ mutant (data
not shown). Our data suggested that vacJ affects binding of
antibody to exposed LOS but not outer membrane protein
epitopes. Since mAb 4C4 is IgG and TEPC-15 is IgA, the effect on
antibody binding and killing was not specific to IgM. This suggests
that our observations about natural antibody in NHS could be
because the bactericidal antibody targeting LOS is predominantly
IgM.
Figure 2. Characterization of vacJ and yrb mutants. (A) Effect of mutations in vacJ and genes of the yrb ABC transporter on serum resistance of
strain R2866. Survival was determined over 60 min in 5% normal human serum and expressed relative to controls in which complement was
inactivated. (B) Representative histogram comparing the binding, as measured by fluorescence intensity (x-axis), of total IgM purified from normal
human serum to parent strain (WT) or vacJ by flow cytometry. Control performed without IgM (C) Percent IgM binding for each mutant was
determined by calculating the percentage of 50,000 events with an increase in mean fluorescence intensity following incubation in 5% heat-
inactivated normal human serum compared to no serum controls. (D) Survival of mutants in 10% normal human serum in the presence (black bars) or
absence (white bars) of Mg-EGTA to inhibit the classical pathway of complement activation. Values represent two independent experiments in
triplicate 6 SD.
*P,0.05,
**P,0.01,
***P,0.001.
doi:10.1371/journal.ppat.1001247.g002
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membrane stability
To test whether vacJ and yrb ABC transporter genes affect the
integrity of the outer membrane, we analyzed the sensitivity of the
mutants to small antimicrobial compounds, including vancomycin
(MW 1449), novobiocin (MW 613), bacitracin (MW 1423), and
polymyxin-B (MW 1302). There was no difference in sensitivity to
these compounds compared to the parent strain suggesting that
the outer membrane barrier of the mutants is largely intact (data
not shown). We then addressed the stability of the outer
membrane by the addition of EDTA, which chelates divalent
cations and compromises the outer leaflet by interrupting
intermolecular associations between LOS phosphate groups. A
concentration of 25 mM EDTA had no effect on the parent strain,
but resulted in a .3-log decrease in viability for each of the
mutants (Fig. 4A). Similarly, the mutants were sensitive to the
detergent deoxycholate at a concentration 4-fold lower than that
required to inhibit growth of the parent strain (data not shown).
Our observations of increased sensitivity to EDTA and deoxy-
cholate demonstrated that the stability of the outer membrane was
impaired in the mutants. Next, we compared the physical
properties of the outer leaflet of the mutants by measuring the
rate of uptake of 1-N-phenylnaphthylamine (NPN), a probe that
changes fluorescence upon transfer from a hydrophilic to
hydrophobic environment. We predicted that higher phospholipid
content would increase the hydrophobic character of the cell
surface of the mutants. As shown in Fig. 4B, vacJ and yrbE mutants
had more rapid NPN uptake than the wild type strain, demon-
strating that both mutants have increased surface hydrophobicity.
In addition, we directly compared the content of surface exposed
phospholipids by treating whole cells with phospholipase C and
then detecting released diacylglycerol using thin layer chromatog-
raphy (Fig. 4C). In comparison to the parent strain, amounts of
released diacylglycerol were increased in vacJ (spot density
increased 219%) and yrbE (spot density increased 143%) mutants,
showing that the amount of surface phospholipid accessible to
phospholipase C treatment was increased in the mutants. The
similar results for each mutant provided further evidence that vacJ
and yrb genes act in the same pathway and were consistent with
their previously proposed function in E. coli in excluding
phospholipids from the outer leaflet described [20]. Together
our findings suggested that maintaining the asymmetry of the
outer leaflet by the exclusion of phospholipids is important in
limiting recognition of surface oligosaccharide epitopes by
antibody.
Expression of vacJ and yrb ABC transporter genes
correlates with serum resistance in clinical isolates
To investigate the relationship between outer leaflet stability
and serum resistance in NTHi, we compared the sensitivity of
serum resistant and serum sensitive clinical isolates to EDTA. As
shown in Fig. 5A, serum resistant isolates were significantly more
resistant to EDTA than serum sensitive isolates. We then
determined whether differences in serum resistance and resistance
to EDTA correlated with the expression of vacJ and yrb genes by
qRT-PCR. As shown in Fig. 5B, vacJ expression was ,5-fold
higher in serum resistant strains compared to serum sensitive
isolates. In addition, yrbE and yrbD expression was ,3-fold higher
Figure 3. Effect of vacJ and yrb mutants on antibody binding and bactericidal activity. Binding of (A) mAb 4C4 to the LOS structure Gala1-
4Gal or (B) mAb TEPC-15 to the LOS structure phosphorylcholine was compared by flow cytometry for the mutants indicated. Percent mAb binding
for each mutant was determined by calculating the percentage of 50,000 events with an increase in mean fluorescence intensity compared to no
primary antibody controls. (C) Effect of mutations in vacJ and genes of the yrb ABC transporter on the bactericidal effect of mAb 4C4. Bactericidal
assays were performed with (white bars) or without (black bars) mAb with 5.0% normal mouse serum as a complement source. Values represent two
independent experiments in triplicate 6 SD.
*P,0.05,
***P,0.001.
doi:10.1371/journal.ppat.1001247.g003
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and 5D). To further investigate the relationship between serum
resistance and vacJ expression, we serially passaged strain H725, a
serum sensitive clinical isolate, in 2.5% NHS to select for variants
with an increasing capacity to resist the bactericidal effect of
serum. With each passage H725 became more serum resistant and
this adaptation was associated with a stepwise increase in vacJ
expression and resistance to EDTA (Fig. 6A–C). Our data suggest
that among clinical isolates differences in serum resistance
correlate with the level of expression of vacJ and its effect on
stability of the outer leaflet of NTHi.
Discussion
Although generally co-existing in a commensal relationship
with its host, NTHi is able to survive the robust inflammatory
response it induces in normally sterile sites in the respiratory tract
such as the lung. Since humans are serially colonized beginning
early in childhood, prior exposure to NTHi, as well as to other
microbial species that induce cross reactivity, provides an
abundant source of natural antibody [22,23]. Individuals with
defects in generating antibody are particularly susceptible to
recurrent respiratory tract infection with NTHi [24]. To survive
the inflammatory response in the LRT, this pathogen has to
evade the effects of the host’s pool of pre-existing antibody, which
when bound to the bacterial surface activates complement and
induces lytic killing. In this report we used a serum killing assay to
show that survival of NTHi isolated from the LRT is associated
with increased resistance to the complement-dependent bacteri-
cidal effect of antibody. Additional evidence in support of this
conclusion is the finding that serum resistance was highest among
the isolates obtained at the time of COPD exacerbations when
clinical signs of inflammation, such as increased production of
sputum, are more pronounced. Although antibodies of other
isotypes can be bactericidal, we found that most of the natural
bactericidal antibody present in NHS is IgM. Our findings
demonstrate that serum killing correlates with binding of natural
IgM followed by activation of the classical pathway of com-
plement. Observations on the prominence of anti-LOS IgM in
the bactericidal activity of NHS correlate with previous reports
looking at natural bactericidal antibody present in animal sera
[25]. Findings in the current study are also consistent with prior
Figure 4. Effect of mutations in vacJ and genes of the yrb ABC transporter on outer membrane characteristics. (A) To compare outer
membrane stability, following overnight culture of the strain indicated, viable counts were obtained after incubation at 37uC for 4 h in the presence
(white bars) or absence (black bars) of 25 mM EDTA. Values represent two independent experiments in triplicate 6 SD.
*P,0.05. (B) To compare
surface hydrophobicity, the rate of uptake of membrane permeant 1-N-phenylnaphthylamine (NPN) was monitored by fluorescence. NPN was added
at the time indicated and a representative experiment shown. (C) To compare amounts of surface phospholipids, diacylglycerol (boxed area) released
by phospholipase C treatment of whole bacteria was detected by thin layer chromatography. Lane 1; diacylglycerol (standard), Lane 2 and 3; R2866
(wild type), Lane 4 and 5; 32F2 (vacJ mutant), Lane 6 and 7; 69G3 (yrbE mutant).
doi:10.1371/journal.ppat.1001247.g004
Serum Resistance in H. influenzae
PLoS Pathogens | www.plospathogens.org 6 January 2011 | Volume 7 | Issue 1 | e1001247reports from this laboratory using a mouse model of airway
infection showing that complement and natural antibody protect
the host from NTHi [26].
Previous analysis of serum resistance in NTHi has been limited
by the marked heterogeneity within and between strains. This is
largely caused by the rapid variation in the expression of surface
Figure 5. Membrane stability and vacJ and yrb expression among clinical isolates. (A) Outer membrane stability of serum sensitive (n=31)
compared to serum resistant (n=16) clinical isolates. Following overnight culture, viable counts were obtained after incubation at 37uC for 4 h with
or without 25 mM EDTA. Values represent two independent experiments in triplicate 6 SD.
*P,0.05, Serum sensitive (SS), Serum resistant (SR). (B)
Relative expression of vacJ mRNA, (C) yrbD and (D) yrbE by qRT-PCR in serum sensitive (white bar, n=7) and serum resistant isolates (black bar, n=7).
Error bars indicate SD,
**P,0.01.
doi:10.1371/journal.ppat.1001247.g005
Figure 6. Repeated serum treatment selects for serum resistance, increased vacJ expression, and increased outer membrane
stability. (A) Serum sensitive clinical isolate H725 was treated three times in 2.5% NHS and survival quantified after the passage indicated. (B)
Following each passage in the bactericidal assay survivors were tested for relative expression of vacJ mRNA by qRT-PCR and (C) survival in the
presence of 25 mM EDTA. Values represent two independent experiments in triplicate 6 SD.
*P,0.05,
***P,0.001.
doi:10.1371/journal.ppat.1001247.g006
Serum Resistance in H. influenzae
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of the organism to escape antibody-dependent, complement-
mediated killing. Several specific oligosaccharide structures that
contribute to serum resistance have been described. Some strains
express siayltransferases that use serum CMP-NANA to cap the
oligosacchaide with sialic acid, which inhibits the activation of
complement through the alternative pathway [16]. The disaccha-
ride Gala1-4Gal, which mimics the human P
k blood group
antigen, blocks recognition by anti-LOS antibodies [13]. The
oligosaccharide structures requiring the galactosyltransferase LgtC
affects expression of Gala1-4Gal modulating deposition of C4b
and activation of the classical pathway [15]. These oligosaccharide
decorations are each variably expressed within and between
strains. Our finding that 8 of the 13 genes necessary for the
expression of serum resistance in a highly serum resistant NTHi
strain function in biosynthesis of the surface oligosaccharide
highlights its central role in this phenotype and the pathogenicity
of the organism. In addition, we demonstrate that the oligosac-
charide is the major target of bactericidal human antibody. This
may explain the predominance of natural IgM in targeting the
NTHi oligosaccharide, since antibody to LPS antigens is
dominated by IgM generated by B-1 cells [27]. For example, a
large proportion of B-1 cells generate IgM reactive with
phosphorylcholine [28].
The selection for a more serum resistant phenotype in the LRT
correlated with increased expression of vacJ and yrb genes, which
alter cell surface characteristics and thereby limit the binding of
bactericidal antibody. The identification of VacJ and an ABC
transporter with related function as necessary for the expression of
serum resistance shows that surface characteristics other than
structural components of the oligosaccharide contribute to serum
resistance of NTHi. The lipoprotein VacJ was previously identified
as a virulence determinant contributing to intracellular survival by
Shigella flexneri [29]. The group of Silhavy proposed that VacJ acts
with the Mla ABC transporter to maintain the lipid asymmetry of
the outer membrane by recycling phospholipids from the outer
leaflet back to the inner leaflet [20]. In E. coli, mutants lacking
these genes were more sensitive to the presence of SDS plus
EDTA added to solid media, but not to antibiotics that need to
access targets in the periplasmic space. These observations
indicated that 1) stability of the outer leaflet generated through
intermolecular bridging of LPS by divalent cations was compro-
mised by the accumulation of phospholipids and 2) the
permeability barrier of the outer leaflet remains largely intact in
the mutants. We observed similar characteristics of mutants in vacJ
and Mla ABC transporter homologs in NTHi. In addition, we
provided direct evidence that vacJ and yrb genes function in
determining key characteristics of the cell surface (i.e. its
hydrophobicity) and that these genes affect amounts of surface
exposed phosholipid. The increase in antibody binding and killing
seen in these mutants provides a new insight into how these
physical characteristics of the outer membrane contribute to serum
resistance. Our results suggest that the intramolecular forces
bridging LOS molecules also serve to limit binding of antibodies to
the oligosaccharide. Thus, when phospholipids are more thor-
oughly excluded (high expression of vacJ and yrb genes), LOS
molecules are more tightly packed and accessibility of LOS
epitopes is restricted (serum resistance). Whereas when phospho-
lipids accumulate in the outer leaflet (low expression of vacJ and yrb
genes), intermolecular associations of LOS molecules are inter-
rupted allowing for increased access of oligosaccharide epitopes
recognized by bactericidal antibodies (serum sensitivity).
Interestingly, the expression of vacJ and yrb genes, which are
required for serum resistance, is variable within and between NTHi
strains. Serum resistant isolates demonstrated increased levels of
transcription compared to serum sensitive isolates and serial passage
of a sensitive isolate in serum selected for increased resistance and
resulted in a higher level of vacJ expression. Thus, differences in
transcription of vacJ are another factor accounting for the marked
differences in serum resistance that characterizes this species. It is
somewhat surprising that for many clinical isolates levels of vacJ
expression is low enough to affectthe stability of the outer membrane.
This suggests that some level of phospholipid accumulation in the
outer leaflet is tolerated by NTHi and implies that there must be an
advantage to a less stable, more hydrophobic outer membrane,
particularly during colonization when restricting recognition by
antibody may be less critical for survival. It appears, however, that
this fitness advantage is lost during infection of the lung when
increased vacJ and yrb gene expression is selected for. Because NTHi
resides in the respiratory tract where it is not exposed to the detergent
effect of bile in the intestine, the physical requirements of its outer
membrane may be different from the paradigm described in the
classic studies based on enteric bacteria [30].
In conclusion, we show that resistance to the bactericidal effect
of immunoglobulin together with complement correlates with the
ability of NTHi to infect the human LRT. Analysis of a serum
resistant isolate revealed that genes contributing to the biosynthesis
of its surface oligosaccharide are required for this phenotype. In
addition, we describe a novel mechanism for serum resistance
whereby NTHi limits the binding of bactericidal anti-LOS
antibody by increasing the exclusion of surface phospholipids.
Materials and Methods
Bacterial strains and growth conditions
Strains used in this study are listed in Table 2. COPD strains.
Strains were isolated from expectorated sputum samples as part of
a prospective study at the Buffalo VA Medical Center (4). COPD
exacerbation strains fulfilled the following criteria: 1) First isolation
of the strain in an adult with COPD based on molecular typing of
isolates recovered from monthly sputum cultures; 2) NTHi is the
only potential pulmonary pathogen isolated in the sputum sample;
3) simultaneous onset of clinical symptoms of an exacerbation
(increased sputum volume, increased sputum purulence and
increased shortness of breath compared to baseline symptoms).
Non-exacerbation strains were from patients with COPD during
clinically stable periods who fulfilled criteria 1 and 2 but symptoms
unchanged from baseline upon acquisition of the strain. Upper
respiratory tract strains. 25 NTHi strains were isolated from throat
cultures of 25 healthy children attending 17 different day care
centers [31,32]. Each isolate had a different pulse-field gel
electrophoresis pattern and was confirmed to be H. influenzae
(and not non-hemolytic H. haemolyticus) based on previous criteria
[1,33]. The absence of bexA and bexB confirmed that the isolates
were not capsule-negative variants.
Strains were routinely grown at 37uC in brain heart infusion
broth (Becton Dickinson) supplemented with 2% Fildes enrich-
ment (Remel) and 20 mg/ml b-NAD hydrate (NAD; Sigma). H782
was created from strain Rd by transformation with a PCR product
from outer membrane protein P2 locus of strain 2019 followed by
screening for expression of the surface epitope recognized by mAb
7B11 epitope [21].
Ethics statement
The strains from adults with COPD were obtained from
subjects enrolled in a study at the Buffalo VA Medical Center that
was approved by the IRB of the VA Western NY Healthcare
System. All subjects provided written informed consent. Strains
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reviewed by IRB Health at the University of Michigan, were
deemed EXEMPT on the basis of: EXEMPTION #4 (45 CFR
46.101(b)(4)), because the data were collected and analyzed
without personal identifiers attached to the bacterial isolates.
In vitro transposon mutagenesis, DNA transformation
and transposon library construction
Mariner mutants of strain R2866 were created by in vitro
transposon mutagenesis as previously described [34]. Briefly, in
vitro transposition reactions were carried out on NTHi genomic
DNA treated with purified MarC9 transposase and pEMspec [35].
To repair gaps, reactions were ethanol-precipitated and resus-
pended in the gap repair buffer [50 mM Tris (pH 7.8)], 10 mM
MgCl2, 1 mM DTT, 100 nM dNTP, and 50 ng of BSA] and then
treated with T4 DNA polymerase (Invitrogen) and E. coli DNA
ligase (Invitrogen) [36]. DNA was transformed into competent
R2866 by the method of Herriott et al [37] and transformants
where selected for on sBHI agar (1%) plates containing
spectinomycin (100 mg/ml).
Identification of serum sensitive transposon mutants
To identify NTHi genes essential for serum resistance, mariner
transposon mutants were screened in a 96-well serum bactericidal
assay. Following growth from single colonies in 200 ml sBHI,
mutants were diluted to 10
5 CFU/ml and 10 ml of the culture
solution was added to 90 ml consisting of 55 ml PBS, 30ml Hank’s
buffer (Ca
2+,M g
2+) and 5 ml of normal human serum (NHS).
Serum was obtained from a single donor for the initial screen to
minimize variability in screening large numbers of mutants.
Bacteria were incubated at 37uC for 1 h with shaking before the
reaction was stopped at 4uC. Controls included serum from the
same donor treated at 56uC for 30 min to inactivate complement.
Mutants showing .90% killing in the primary screen were further
tested to minimize false positives. Genomic DNA was used to back
transform competent R2866 and three spectinomycin resistant
colonies were picked and rescreened in the bactericidal assay. The
site of the transposon insertion was determined for mutants in
which 3/3 back transformants were serum sensitive.
Arbitrary primed PCR and nucleotide sequence
The primers used for inverse PCR are listed in Table 2. The
first round of PCR was performed in a final volume of 50 ml.
Primers (0.5 mmol/reaction mixture) ARB1 paired with mag2F3
(transposon) were used in PCR under the following conditions: 1
cycle of 95uC for 8 min; 6 cycles of 95uC for 30 s, 30uC for 30 s,
and 72uC for 1.5 min; 30 cycles of 95uC for 30 s, 45uC for 30 s,
and 72uC for 2 min; and 72uC for 5 min. A second round of PCR
Table 2. The list of strains, plasmids and primers used in this study.
Strains, plasmids, primers Description Reference
Strains
Rd Rough type d isolate, genome sequence reference strain [46]
2019 Clinical isolates of nontypeable H. influenzae [47]
R2866 NTHi clinical isolate from the bloodstream [18]
32F2 R2866 vacJ disrupted by mariner Tn This study
49E3 R2866 yrbD ABC transporter periplasmic protein disrupted by mariner Tn This study
66B5 R2866 yrbB NTP binding protein disrupted by mariner Tn This study
69G3 R2866 yrbE ABC transporter perimease disrupted by mariner Tn This study
H782 Rd transformed with DNA of 2019 to express m7B11 epitope on OMP P2 This study
H725 Clinical isolate of NTHi from lower respiratory tract This study
H816 H782 transformed with DNA of 32F2 to disrupt vacJ This study
vacJ::Km R2866 transformed with pUCDvacJKm
R to disrupt vacJ This study
vacJ::Km,DyrbE 69G3 transformed with pUCDvacJKm
R to disrupt vacJ This study
Plasmids
pEMspec Contains mariner Tn carrying Spec
R cassette [35]
pUCDvacJKm
R vacJ replaced with Km
R cassette from pUC4K This study
Primers
ARB1 GGCCACGCGTGCACTAGTAC (N)10 TACNG [48]
ARB2 GGCCACGCGTGCACTAGTAC [48]
MAG2F3 GGAATCATTTGAAGGTTGGTA [49]
MAG2F4 ACTAGCGACGCCATCTATGTG [49]
Hi_vacJ_H3_F2 AAGCTTAAAATGTAGCAGGTAAACGTCG This study
Hi_vacJ_R1 ACGTAATGCCATCGTTTTAGAC This study
Hi_vacJ_B1_F1 CGGGATCCTAAACAGAAAAGTGCGGTAAAAATT This study
Hi_vacJ_B1_R1 CGGGATCCTTTTAATCCTTACATAAATATGGGATTATTC This study
Hi_vacJ_F9 CGTGCGTTCTTTAATGACTCTCG This study
Hi_vacJ_R7 CAATGTGAAGTGGAAAAGCCCC This study
doi:10.1371/journal.ppat.1001247.t002
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with the internal mag2F4 (transposon) primer under the following
conditions: 1 cycle of 95uC for 8 min, 30 cycles of 95uC for 45 s,
55uC for 45 s, and 72uC for 1.5 min, followed by 72uC for 10 min.
PCR products were purified with the QIAGEN PCR cleanup kit
and then used for nucleotide sequence analysis.
Construction of DvacJ::Km
R mutant
The vacJ gene and flanking regions were amplified from strain
R2866 using primers Hi_vacJ_H3_F2 and Hi_vacJ_R1 and
cloned into pCR2.1TOPO vector. The entire vacJ gene was
deleted by inverse PCR using Hi_vacJ_B1_F1 and Hi_vacJ_
B1_R1 primers introducing a BamHI site. The resulting DvacJ
fragment was subcloned into pUC19 and the kanamycin-
resistance cassette from pUC4K was then inserted using BamHI
creating pUCDvacJ::Km
R. This plasmid was used to transform
strains R2866 and 69G3 strains creating single and double
DvacJ::Km
R mutants. Disruption of vacJ was confirmed by PCR
using primers vacJ_ F9 and Hi_vacJ_R7 located outside of the
originally cloned region.
Serum bactericidal assays
To test clinical isolates in bactericidal assays, serum was
collected, pooled and stored at -80uC from 5 healthy adult
volunteers. Assays were performed with 20 ml of a suspension of
midlog phase organisms (OD620 0.3–0.4) diluted to 10
5 CFU/ml
in Hank’s buffer with Ca
2+ and Mg
2+ (GIBCO, Auckland, New
Zealand), 10 ml of NHS, 110 ml of PBS and 60 ml of Hank’s buffer
with Ca
2+ and Mg
2+. After incubation for 60 min at 37uC with
rotation, the assay was stopped by cooling to 4uC and dilutions
were made for quantitative culture. To inhibit the classical
pathway of complement, veronal buffer (pH 7.4) containing
70 mM NaCl, 140 mM glucose, 0.1% gelatin, 7 mM MgCl2, and
10 mM Mg-EGTA was substituted for Hank’s buffer [38]. To
calculate the percent survival, viable counts were compared to
controls in which complement activity had been eliminated by
heat-inactivation at 56uC for 30 min. IgG was removed from NHS
using a protein G column according to the manufacturer’s
instructions (GE Healthcare, Uppsala, Sweden). The flow-through
of IgG column was used for purification of IgM. Purified IgM was
obtained by using IgM purification column according to the
manufacturer’s instructions (GE Healthcare, Uppsala, Sweden).
The concentration of purified IgG and IgM were determined by
the Micro BCA protein assay (Pierce Chemical Co.) and a titrated
enzyme-linked immunosorbent assay (ELISA). Where indicated,
three-four week old baby rabbit serum was used as a complement
source (Pel-Freez Biologicals, Rogers, AR).
Colony immunoblotting
Colonies lifted onto nitrocellulose were immunoblotted to
separate phase variants as previously described [39]. Briefly, the
LOS and ChoP epitope on colonies lifted onto nitrocellulose were
detected using mAbs 4C4 against Gala1-4Gal [40] and TEPC-15
(Sigma) against phosphorylcholine followed by alkaline phospha-
tase–conjugated anti– mouse IgG and IgA, respectively. Single
colonies of a uniform phenotype were selected and confirmed by
repeated immunoblotting.
Labeling of surface proteins
200 ml of a suspension of midlog phase organisms, R2866 and
vacJ mutant, (OD620 0.5) was pelleted, washed twice with 1 ml of
10 mM carbonate buffer (pH 8.5), and then resuspended in 200 ml
of buffer (10 mM carbonate, 1 M urea). Surface-exposed lysine
residues were labeled with 10 ml of Cy5 (400 pmol, GE
Healthcare) on ice in the dark for 20 min [41]. Reactions were
stopped by addition of 20 ml of 10 mM lysine. The resulting pellets
were washed twice with 500 ml of carbonate buffer, centrifuged,
and resuspended in 200ml 1% BSA. Cy5 binding on bacteria was
analyzed by flow cytometry with 10,000 events analyzed per
sample.
Deposition of complement factor 3
R2866 and vacJ mutant were grown to an OD620 ,0.5. The
bacterial suspension (200 ml) was pelleted and resuspended in
Hank’s buffer with Ca
2+ and Mg
2+ (GIBCO, Auckland, New
Zealand) with 5% fetal calf serum (HyClone) and incubated with
5ml of baby rabbit sera for 1uh. Bacteria were pelleted and
resuspended in Hanks’ buffer plus 5% fetal calf serum containing a
1:100 dilution of a FITC-conjugated polyclonal goat anti-rabbit
C3 antibody (MP Biomedical Cappel, Irvine, CA) for 60 min at
4uC in dark and analyzed by flow cytometry.
Quantitative real-time RT-PCR
Total cellular RNA was extracted from mid-log phase grown
NTHi clinical isolates by using the RNeasy mini Kit (QIAGEN).
To eliminate genomic DNA, samples were incubated with 20 U of
RNase-free DNase (QIAGEN) for 20 min at 25uC using the
RNeasy columns, according to the manufacturer’s instructions. 1
to 1.5 mg RNA was used for reverse transcription in a 20 ml
reaction with the high-capacity cDNA reverse transcription kit
(Applied Biosystems) together with random primers and 20 U
RNase inhibitor (Promega). 1 ml of cDNA from this reaction was
used as template with 0.5 mM primers (vacJ-F: 59-TCCGTGG-
GCATTAGTGAAAT-39; vacJ-R:59-AATTCTGCATTATTGA-
GATTTTTCG-39; yrbD-F:59-TACTGTGACGGCAACTTTC-
G-39; yrbD-R:59-AATCGCGATGCTTACTTTCG-39; yrbE-F:59-
TCGTGTTAATCGATTTTTCTGC-39; yrbE-R:59- CAGGGC-
CTAATTCTCGTAAAAG-39) and SYBR Green PCR Master
Mix in a 20-ml reaction (Applied Biosystems). Standard runs of the
reactions on fast optical 96-well reaction plates (Applied
Biosystems) were carried out using the StepOnePlus Real-Time
PCR system (Applied Biosystems). The gyrA gene (primers gyr-F:
59-GCGTGTTGTGGGTGATGTAA-39; and gyr-R: 59- GTT-
GTGCCATACGAACGATG-39) was used as the internal stan-
dard gene for RNA quantity normalization [42]. Quantitative
comparison was obtained through the DDCT method as described
at http://www3.appliedbiosystems.com/cms/groups/mcb_support/
documents/generaldocuments/cms_041435.pdf.
Antibody binding assays
200 ml of mid-logarithmic-phase bacterial cells (OD620 0.5) were
pelleted and resuspended in 200 ml of Hanks’ buffer without Ca
2+
and Mg
2+ (Gibco) supplemented with 5% fetal calf serum
(HyClone). Primary antibodies (1:200 for heat inactivated NHS,
1:50 for mAb 4C4, 1:1000 for mAb TEPC-15, and 1:100 for mAb
7B11) were added to reaction and then incubated at 37uC for
60 min. Bacteria were pelleted and incubated with Hanks’ buffer
without Ca
2+ and Mg
2+ plus 5% fetal calf serum containing a
1:200 dilution of the appropriate secondary antibody; goat anti-
human IgG-FITC conjugate (Sigma), goat anti-human IgM FITC
conjugate (Sigma), anti-mouse IgG-FITC conjugate (Sigma), anti-
mouse IgA-FITC conjugate (Sigma) for 60 min at 4uC in the dark.
Reaction mixtures were then washed and resuspended in 200 mlo f
PBS containing 1% bovine serum albumin and 0.5% paraformal-
dehyde. A total of 50,000 cells were collected for each sample. All
samples were subjected in full volume to flow cytometry analysis
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groups were compared using FlowJo software (Tree Star).
Growth inhibition assays
Ethylenediaminetetraacetate (EDTA) was added to 500 mlo fa n
overnight culture in sBHI broth (25 mM final concentration) and
incubated at 37uC for 4 h under aeration prior to obtaining viable
counts. The minimum inhibitory concentration of vancomycin,
novobiocin, bacitracin, polymyxin-B and deoxycholate was
determined by broth microdilution method. Briefly, 96-well plates
containing 2-fold dilution of chemical were prepared in sBHI and
wells were inoculated with ,5610
5 cfu/ml of overnight bacterial
cultures. Viable counts were determined after incubation for 18–
24 h at 37uC.
NPN uptake assay
1-N-phenylnaphthylamine (NPN) (Sigma) uptake assay was
performed as described previously [43]. Briefly, bacteria were
grown to OD620 0.5 in sBHI broth. Pellets were washed and
resuspended in 5 mmol/L HEPES buffer (pH 7.2). NPN was
dissolved in acetone for a 500 mmol/L stock solution and diluted
to 40 mmol/L in HEPES buffer. The NPN solution (50 ml) was
added after 15 s to the bacterial suspension (150 ml) for a final
NPN concentration of 10 mmol/L. Fluorescence was monitored
for a total of 90 s using the PTi fluorescence system (Photon
Technology International), with excitation at 350 nm, emission at
420 nm, and slit width of 2 nm.
Phospholipase C treatment
Phospholipase C treatment and thin layer chromatography
(TLC) were performed as described previously [44]. 1 L of each
bacterial culture were grown in sBHI broth to OD620 0.5 and
centrifuged 65000 g for 20 min. Pellets were washed once and
resuspended in a sucrose-PBS-MgCl2 buffer [0.4M sucrose,
16PBS, 15 mM MgCl2, (pH 7.5)] to a final volume of 1.8 ml.
200 ml aliquots of bacterial suspension were treated with 5u of
phospholipase C from Bacillus cereus (Sigma) for 20 min at 37uC.
Reactions were stopped by adding 600 ml CHCl3-methanol 1:2 (v/
v). The lipids were extracted by the method of Bligh and Dyer
[45]. Lipid samples were normalized to protein content and
separated by TLC on glass backed silica gel 60 plates (Merck) with
CHCl3-Acetone 94:4 (v/v) solvent system and were stained by
iodine. The standard was 10 mg of 1,2-diglycerides from pig liver
(Serdary Research Lab.).
Statistical analysis
All data were analyzed using StatView software (Abacus
Concepts, Cary, NC). The significance of differences between or
among groups was examined using ANOVA followed by Tukey or
Dunnett post-tests.
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